Core Viewpoint - China Resources Vientiane Life reported a revenue of 18.022 billion RMB for the fiscal year ending December 31, 2025, marking a year-on-year increase of 5.06% and a net profit attributable to equity shareholders of 3.969 billion RMB, up 10.31% year-on-year [3] Group 1: Financial Performance - The company proposed a final dividend of 0.509 RMB per share and a special dividend of 0.341 RMB per share [3] - Basic earnings per share were reported at 1.739 RMB [3] Group 2: Business Strategy - Revenue growth was primarily driven by the continuous expansion of managed scale and improved efficiency in commercial retail [4] - The company is focusing on strategic expansion in shopping centers, actively pursuing merger and acquisition opportunities, and enhancing long-term operational rights projects [4] - The office segment is concentrating on core cities and deepening strategic cooperation with financial institutions and state-owned enterprises [4] Group 3: Operational Management - The company is implementing refined operational management strategies, including category-based management and a strong focus on high-end luxury products [4] - The urban flagship strategy aims to strengthen brand positioning through product excellence [4] - The company is enhancing its operational efficiency and establishing benchmark stores [4] Group 4: Technology and Innovation - The property segment is committed to technology-driven urban space operation services, focusing on core cities and major clients [5] - The company is expanding its diversified growth channels and actively planning strategic acquisition opportunities [5] - The membership business is being developed to create new performance growth points, focusing on points, rights, and data [5] Group 5: Sustainability Initiatives - The company is committed to sustainable development, integrating ESG principles throughout its operations [6] - It aims to achieve peak carbon emissions by 2030 and carbon neutrality by 2050, aligning with national dual carbon strategies [6]

Core Insights - In 2025, China Resources Vientiane Life achieved a revenue of 18.022 billion yuan, representing a year-on-year growth of 5.1%, with core net profit increasing by 13.7% to 3.95 billion yuan [1] - The company opened 14 shopping centers during the year, totaling 135 operational projects, with 54 projects ranking first in local market retail sales and 105 in the top three [1] Revenue Breakdown - Commercial channel revenue reached 6.906 billion yuan, up 10.1% year-on-year [1] - Property channel revenue was 10.847 billion yuan, with a modest growth of 1.1% [1] - Ecosystem business revenue surged to 269 million yuan, marking a significant increase of 72.2% [1] Retail Performance - The operational shopping centers generated retail sales of 266 billion yuan, reflecting a year-on-year growth of 23.7% [1] - Luxury project retail sales grew by 18.5%, while non-luxury projects saw a 26.9% increase [1] Office Market Recovery - The office sector showed signs of recovery, with the company's office property rental rate increasing by 3.6 percentage points to 77.2% [2] - New leasing area reached 277,000 square meters, a year-on-year growth of 19% [2] Strategic Focus - The management indicated that the commercial real estate sector is becoming more market-oriented, moving away from traditional real estate attributes [2] - The company plans to focus on core cities and high-quality projects, aiming to enhance project density in first and second-tier cities while selectively entering third-tier cities with large populations and concentrated industries [2][4] Project Development - In 2025, the company developed 12 third-party projects, with an average gross floor area exceeding 100,000 square meters [4] - As of year-end, there were 72 projects yet to open, including 32 from the parent company and 40 third-party projects [4]

Group 1 - BlackRock reduced its stake in CK Hutchison Holdings (00001) by selling 17,933,936 shares at an average price of HKD 59.5998 per share, totaling approximately HKD 1.069 billion [1] - Following the sale, BlackRock's remaining shareholding is approximately 180 million shares, representing a stake of 4.69% in the company [1]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Melco International Development (00200.HK) by 369,000 shares on March 30, with a total net reduction of 688,500 shares over the last five trading days [1] - Over the past 20 trading days, there have been 13 days of net increases in southbound fund holdings, totaling 4.8452 million shares [1] - As of now, southbound funds hold 156 million shares of Melco International Development, representing 6.83% of the company's total issued ordinary shares [1] Group 2 - Melco International Development Limited primarily engages in entertainment and hotel businesses as an investment holding company [1] - The company operates through two segments: the entertainment and hotel segment, which includes casino operations and hotel services, and the other segment, which focuses on investment activities [1]

Core Insights - Southbound funds increased their holdings in Alibaba Health (00241.HK) by 8.332 million shares on March 30 [1] - Over the past 5 trading days, there were 3 days of net increases in holdings, totaling 4.2241 million shares [1] - In the last 20 trading days, there were 13 days of net increases, amounting to 38.2002 million shares [1] - Currently, southbound funds hold 2.019 billion shares of Alibaba Health, representing 12.47% of the company's total issued ordinary shares [1] Company Overview - Alibaba Health Information Technology Co., Ltd. provides industrial internet solutions for the medical and pharmaceutical industry [1] - The company is the flagship platform of Alibaba Group in the health sector, primarily engaged in the sales of pharmaceutical health products [1] - It operates a pharmaceutical e-commerce platform and consumer healthcare service platform, utilizing cloud computing and big data for traceability and digital healthcare [1]

Core Viewpoint - The company is expected to achieve strong revenue and profit growth in 2025, with total revenue projected at 13.042 billion yuan, a year-on-year increase of 38.4%, and product revenue at 11.896 billion yuan, up 44.6% [1][2] - The company has established significant partnerships with Roche, Takeda, and Eli Lilly, highlighting its strong R&D capabilities and increasing international recognition [1] - The company is becoming a leading pharmaceutical enterprise in China, with a competitive global innovation pipeline, and aims to become a world-class biopharmaceutical company [1] Financial Performance - In 2025, the company reported total revenue of 13.042 billion yuan, a 38.4% increase year-on-year, with product revenue reaching 11.896 billion yuan, up 44.6% [1] - The company achieved a turnaround in IFRS net profit, reporting 814 million yuan in 2025, a significant improvement from a loss of 95 million yuan in 2024, driven by strong revenue growth and improved operational efficiency [1] - Non-IFRS net profit for 2025 was 1.723 billion yuan, a substantial increase from 332 million yuan in 2024, with EBITDA reaching 1.99 billion yuan, up from 412 million yuan in 2024 [1] Commercialization and Product Development - The company has built a leading oncology brand in China and is developing a rising chronic disease innovation brand, with a comprehensive product portfolio and a mature commercialization network [2] - The product portfolio has expanded to 18 products, with 12 included in the national medical insurance, covering oncology, metabolism, and autoimmune diseases [2] - The company’s product revenue of 11.896 billion yuan in 2025 marks its first breakthrough of 10 billion yuan, reflecting the foresight and efficient commercialization execution, with expectations to exceed 20 billion yuan in product revenue by 2027 [2]

Group 1 - Southbound funds reduced their holdings in Baoshan International (03813.HK) by 9,000 shares on March 30 [1] - Over the past 5 trading days, there have been 5 days of net reductions by southbound funds, totaling 1.017 million shares [1] - In the last 20 trading days, there have been 20 days of net reductions, amounting to 2.715 million shares [1] Group 2 - As of now, southbound funds hold 14.371 million shares of Baoshan International, representing 0.27% of the company's issued ordinary shares [1] - Baoshan International Holdings Limited primarily engages in the distribution and retail of sports apparel and footwear [1] - The company operates through two segments: the sales of sports apparel and footwear segment, and the commission sales of licensed counters segment [1]

Group 1 - The core point of the article highlights that southbound funds increased their holdings in Shenzhou International (02313.HK) by 1.0233 million shares on March 30 [1] - Over the past five trading days, there were three days of net reductions in holdings by southbound funds, totaling a net decrease of 894,000 shares [1] - In the last 20 trading days, there were 13 days of net increases in holdings by southbound funds, with a cumulative net increase of 2.4451 million shares [1] Group 2 - As of now, southbound funds hold 10.7 million shares of Shenzhou International, accounting for 7.1% of the company's total issued ordinary shares [1] - Shenzhou International Group Holdings Limited primarily engages in the production and sale of knitted apparel products [1] - The company's main business involves manufacturing knitted products for clients through a combination of OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) [1] - The product categories include sportswear, casual wear, underwear, and other knitted products [1] - The company also engages in trading and property management through its subsidiaries, operating in both domestic and international markets [1]

Core Viewpoint - The company, HuTongDa Network (09878), announced the proposal to elect Mr. Wang Hao as a candidate for the non-executive director of the fourth board of directors during the board meeting scheduled for March 30, 2026 [1] Summary by Relevant Sections - **Board Election** - The board will review and approve the proposal to elect Mr. Wang Hao as a non-executive director candidate [1] - **Term Details** - Mr. Wang's term will commence upon approval by the shareholders' meeting and will last until the end of the fourth board's term, with the possibility of re-election after the term ends [1]

Core Viewpoint - Lianhua Supermarket (00980.HK) reported a decline in revenue for 2025, indicating challenges in the retail sector, particularly in large supermarkets and convenience stores [1] Financial Performance - Revenue for 2025 was approximately RMB 17.753 billion, a year-on-year decrease of about 9.9% [1] - The large-scale supermarket segment saw a decline of approximately 14.7%, while the supermarket segment decreased by about 5.9%, and the convenience store segment fell by around 11.2% [1] - Gross profit amounted to approximately RMB 2.088 billion, down about 12.0% year-on-year, with a gross margin of approximately 11.76%, a decrease of 0.27 percentage points compared to the previous year [1] - The net loss attributable to shareholders for the year was approximately RMB 200 million, representing a 44.18% reduction year-on-year, with a basic loss per share of approximately RMB 0.14 [1]